Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionBarclays Plc
Latest Disclosed Ownership124,229 shares
Latest Disclosed Value $ 9,956,955
Barclays Plc ownership in HAE / Haemonetics Corporation

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 124,229 shares of Haemonetics Corporation (US:HAE) valued at $9,956,954 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 119,308 shares of Haemonetics Corporation. This represents a change in shares of 4.12% during the quarter. The current value of the position is $8,184,207 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (HAE) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

HAE / Haemonetics Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 124,229 4,921 4.12 9,957 71.21 0.0024
2026-03-31 2025-09-30 13F/A-3 HAEMONETICS CORP MASS COM 405024100 119,308 -100,499 -45.72 5,815 -64.54 0.0013
2026-03-19 2025-09-30 13F/A-2 HAEMONETICS CORP MASS COM 405024100 102,533 -117,274 8,242 0.0022
2025-11-12 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 119,308 -100,499 5,815 0.0013
2026-02-27 2025-06-30 13F/A-2 HAEMONETICS CORP MASS COM 405024100 219,807 49,942 29.40 16,400 51.93 0.0038
2025-08-14 2025-06-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 219,807 49,942 16 0.0038
2025-08-13 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 219,807 49,942 16 0.0012
2026-03-17 2025-03-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 169,865 47,730 39.08 10,795 13.19 0.0031
2025-05-15 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 169,865 47,730 11 0.0031
2026-03-19 2024-12-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 122,135 19,602 19.12 9,536 15.71 0.0027
2025-02-13 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 122,135 19,602 10 0.0027
2026-03-31 2024-09-30 13F/A-2 HAEMONETICS CORP MASS COM 405024100 102,533 67,470 192.43 8,242 184.17 0.0022
2024-11-19 2024-09-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 102,533 67,470 8 0.0022
2024-11-15 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 102,533 67,470 8 0.0022
2026-03-23 2024-06-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 35,063 -68,802 -66.24 2,901 -67.28 0.0009
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 35,063 -68,802 3 0.0009
2026-03-24 2024-03-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 103,865 -15,034 -12.64 8,865 -12.82 0.0031
2024-05-15 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 103,865 -15,034 9 0.0031
2026-03-25 2023-12-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 118,899 81,303 216.25 10,167 201.96 0.0037
2024-02-15 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 118,899 81,303 10 0.0037
2026-03-26 2023-09-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 37,596 -6,059 -13.88 3,368 -9.39 0.0021
2023-11-07 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 37,596 -6,059 3 0.0021
2026-03-30 2023-06-30 13F/A-2 HAEMONETICS CORP MASS COM 405024100 43,655 5,606 14.73 3,717 18.04 0.0024
2023-09-20 2023-06-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 43,655 5,606 4 0.0024
2023-08-03 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 43,655 5,606 4 0.0023
2026-03-30 2023-03-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 38,049 15,572 69.28 3,149 78.16 0.0014
2023-05-04 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 38,049 15,572 3 0.0014
2026-03-30 2022-12-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 22,477 16,427 271.52 1,768 295.30 0.0008
2023-02-13 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 22,477 16,427 2 0.0008
2022-11-03 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 6,050 1,614 36.38 447 54.67 0.0005
2022-08-12 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 4,436 -7,822 -63.81 289 -62.76 0.0002
2022-05-16 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 12,258 -62,235 -83.54 776 -80.36 0.0006
2022-02-23 2021-12-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 74,493 17,293 30.23 3,951 -2.15 0.0015
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 74,493 17,293 3,951 0.0004
2021-11-09 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 57,200 19,084 50.07 4,038 59.04 0.0018
2021-08-13 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 38,116 12,717 50.07 2,539 -9.93 0.0012
2021-05-13 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 25,399 23,993 1,706.47 2,819 1,588.02 0.0015
2021-02-11 2020-12-31 13F HAEMONETICS COM 405024100 1,406 -385 -21.50 167 6.37 0.0001
2020-11-12 2020-09-30 13F HAEMONETICS COM 405024100 1,791 -16,239 -90.07 157 -90.27 0.0001
2020-08-12 2020-06-30 13F HAEMONETICS COM 405024100 18,030 -1,335 -6.89 1,614 -16.42 0.0012
2020-05-13 2020-03-31 13F HAEMONETICS COM 405024100 19,365 -40,045 -67.40 1,931 -71.71 0.0015
2020-02-10 2019-12-31 13F HAEMONETICS COM 405024100 59,410 23,880 67.21 6,825 52.31 0.0038
2019-11-15 2019-09-30 13F/A-1 HAEMONETICS COM 405024100 35,530 -5,238 -12.85 4,481 -8.66 0.0028
2019-11-14 2019-09-30 13F HAEMONETICS COM 405024100 35,530 -5,238 4,481 1,036.0123
2019-08-14 2019-06-30 13F HAEMONETICS COM 405024100 40,768 -4,702 -10.34 4,906 23.33 0.0030
2019-05-15 2019-03-31 13F HAEMONETICS COM 405024100 45,470 31,421 223.65 3,978 183.13 0.0027
2019-02-14 2018-12-31 13F HAEMONETICS COM 405024100 14,049 -28,064 -66.64 1,405 -70.88 0.0011
2018-11-14 2018-09-30 13F HAEMONETICS COM 405024100 42,113 -3,505 -7.68 4,825 17.94 0.0033
2018-08-14 2018-06-30 13F HAEMONETICS COM 405024100 45,618 28,453 165.76 4,091 225.72 0.0035
2018-05-15 2018-03-31 13F HAEMONETICS COM 405024100 17,165 5,729 50.10 1,256 89.16 0.0010
2018-02-14 2017-12-31 13F HAEMONETICS COM 405024100 11,436 8,294 263.97 664 370.92 0.0005
2017-11-14 2017-09-30 13F HAEMONETICS COM 405024100 3,142 -10,187 -76.43 141 -73.24 0.0001
2017-08-14 2017-06-30 13F HAEMONETICS COM 405024100 13,329 11,927 850.71 527 824.56 0.0006
2017-05-15 2017-03-31 13F HAEMONETICS COM 405024100 1,402 255 22.23 57 23.91 0.0001
2017-02-14 2016-12-31 13F HAEMONETICS COM 405024100 1,147 -1,047 -47.72 46 -41.77 0.0000
2016-11-14 2016-09-30 13F HAEMONETICS COM 405024100 2,194 -2,162 -49.63 79 -37.30 0.0001
2016-08-12 2016-06-30 13F HAEMONETICS COM 405024100 4,356 -36,341 -89.30 126 -90.90 0.0002
2016-05-16 2016-03-31 13F HAEMONETICS COM 405024100 40,697 33,714 482.80 1,384 517.86 0.0021
2016-02-12 2015-12-31 13F HAEMONETICS COM 405024100 6,983 6,367 1,033.60 224 1,078.95 0.0003
2015-11-13 2015-09-30 13F HAEMONETICS COM 405024100 616 -376 -37.90 19 -52.50 0.0000
2015-08-14 2015-06-30 13F HAEMONETICS COM 405024100 992 -641 -39.25 40 -43.66 0.0000
2015-05-19 2015-03-31 13F/A-1 HAEMONETICS COM 405024100 1,633 -1,331 -44.91 71 -34.86 0.0001
2015-05-14 2015-03-31 13F HAEMONETICS COM 405024100 1,633 71
2015-02-13 2014-12-31 13F HAEMONETICS COM 405024100 2,964 1,076 56.99 109 70.31 0.0001
2014-11-14 2014-09-30 13F HAEMONETICS COM 405024100 1,888 963 104.11 64 100.00 0.0001
2014-08-14 2014-06-30 13F HAEMONETICS COM 405024100 925 -1,263 -57.72 32 -54.29 0.0000
2014-05-15 2014-03-31 13F HAEMONETICS COM 405024100 2,188 -17,737 -89.02 70 -91.63 0.0001
2014-02-13 2013-12-31 13F HAEMONETICS COM 405024100 19,925 -28,455 -58.82 836 -55.72 0.0009
2013-11-14 2013-09-30 13F HAEMONETICS COM 405024100 48,380 -23,939 -33.10 1,888 -36.88 0.0023
2013-08-14 2013-06-30 13F HAEMONETICS COM 405024100 72,319 72,319 2,991 0.0037
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-11-14 2018-09-30 13F HAEMONETICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F HAEMONETICS OPT Put 50,000 4,484 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.